Trends in risk factors, patterns and causes in hospitalized strokes over 25 years: The Lausanne Stroke Registry

Cerebrovascular Diseases

Volumn 24, Issue 1, 2007, Pages 97-103

  Carrera, Emmanuel ^a   Maeder Ingvar, Malin ^a   Rossetti, Andrea O ^a   Devuyst, Gérald ^a   Bogousslavsky, Julien ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Clinique de Valmont Genolier   (Switzerland)

Author keywords

Lausanne Stroke Registry; Stroke care; Stroke, risk factors

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE REGISTRY; EMBOLISM; FEMALE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; MORTALITY; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIABETES COMPLICATIONS; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RISK FACTORS; SMOKING; SWITZERLAND; TIME FACTORS;

EID: 34347375780     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103123     Document Type: Article

References (33)

1. Bogousslavsky J, van Melle G, Regli F: The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
2. Caplan LR, Wityk RJ, Glass TA, et al: New England Medical Center Posterior Circulation registry. Ann Neurol 2004;56:389-398.
3. Moulin T, Tatu L, Crepin-Leblond T, Chavot D, Berges S, Rumbach T: The Besançon Stroke Registry: an acute stroke registry of 2500 consecutive patients. Eur Neurol 1997;38:10-20.
4. Kumral E, Ozkaya B, Sagduyu A, Sirin H, Vardarli E, Pehlivan M: The Ege Stroke Registry: a hospital-based study in the Aegean region, Izmir, Turkey - analysis of 2000 stroke patients. Cerebrovasc Dis 1998;8:278-288.
5. Lee BI, Nam HS, Heo JH, et al: Yonsei Stroke Registry: analysis of 1000 patients with acute cerebral infarctions. Cerebrovasc Dis 2001;12:145-151.
6. Vemmos KN, Takis CE, Georgilis K, et al: The Athens Stroke Registry: results of a five-year hospital-based study. Cerebrovasc Dis 2000;10:133-141.
7. European Stroke Initiative Executive Committee and the EUSI Writing Committee: European Stroke Initiative Recommendations for Stroke Management -update 2003. Cerebrovasc Dis 2003;16:311-337.
8. Adams HP Jr, Adams RJ, Brott T, et al; Stroke Council of the American Stroke Association: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
9. Alberts MJ, Latchaw RE, Selman WR, et al; Brain Attack Coalition: Recommendations for comprehensive stroke centres: a consensus statement from the brain attack coalition. Stroke 2005;36:1597-1618.
10. Rothwell PM, Coull AJ, Giles MF, et al: Change in stroke incidence, mortality, case-fatility, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925-1933.
11. Immonen-Räiha P, Sarti C, Tuomilehto J, et al: Eleven-year trends of stroke in Turku, Finland. Neuroepidemiology 2003;22:196-203.
12. Anderson CS, Carter KN, Hackett ML, et al; Auckland Regional Community Stroke (ARCOS) Study Group: Trends in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke 2005;36:2087-2093.
13. Feigin VL, Lawes CM, Bennet DA, Anderson CS: Stroke epidemiology: a review of populations-based studies of incidence, prevalence, and case fatality in the late 20th century. Lancet Neurol 2003;2:43-53.
14. Benatru I, Rouaud O, Durier J, et al: Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke 2006;37: 1674-1679.
15. Momjian-Mayor I, Baron JC: The pathophysiology of watershed infarction in internal carotid artery disease. Stroke 2005;36:567-577.
16. Ihaka R, Gentleman R: R: a language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
17. Di Carlo A, Lamassa M, Baldereschi M, et al; European BIOMED Study of Stroke Care Group: Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe. Stroke 2003;34:1114-1119.
18. Hanratty B, Lawlor DA, Robinson MB, Sapsford RJ, Greenwood D, Hall A: Sex differences in risk factors, treatment and mortality after acute myocardial infartion: an observational study. J Epidemiol Community Health 2000;54:912-916.
19. 1999 World Health Organisation-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-183.
20. Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;355:1955-1964.
21. Murray CJ, Lauer JA, Hutubessy RC, et al: Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular disease risk. Lancet 2003;361:717-725.
22. Galobardes B, Costanza MC, Bernstein MS, Delhumeau CH, Morabia A: Trends in risk factors for the major 'lifestyle-related diseases' in Geneva, Switzerland, 1993-2000. Ann Epidemiol 2003;13:537-540.
23. Keller R, Krebs H, Hornung R: Der Tabakkonsum der Schweizer Wohnbevölkerung in den Jahren 2001 bis 2005. Bern, Bundesamt für Gesundheit, Gesundheitspolitik, Fachstelle Tabakpräventionfonds, 2006.
24. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;356:1955-1964.
25. Giroud M, Lemesle M, Quantin C, et al: A hospital-based and a population-based registry yield different results: the experience of Dijon. Neuroepidemiology 1997;16:15-21.
26. Kang S, Wu Y, Li X: Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 2004;177:433-442.
27. Amarenco P, Labreuche J, Lavallee P, Touboul PJ: Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-2909.
28. Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classifications of subtype of acute stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
29. Jemal A, Ward E, Hao Y, Thun M: Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-1259.
30. Jamrozik K, Broadhurst RJ, Lai N, Hankey GJ, Burvill PW, Anderson CS: Trends in the incidence, severity, and short-term outcome of stroke in Pearth, Western Australia. Stroke 1999;30:2105-2111.
31. Pajunen P, Paakkonen R, Hamalainen H, et al: Trends in fatal and nonfatal strokes among persons aged 35 to 6 85 years during 1991-2002 in Finland. Stroke 2005;36:244-248.
32. Sarti C, Rastenyte D, Cepaitis Z, Tuomiletho J: International trends in mortality from stroke, 1968 to 1994. Stroke 2000;31:1588-1601.
33. Bonita R, Broad J, Anderson NE, Beaglehole R: Approaches to the problems of measuring the incidence of stroke: The Auckland Stroke Study, 1991-1992. Int J Epidemiol 1995;24:535-542.